NEW YORK (Reuters Health) – In patients with blood cancers who contract COVID-19, CD8 T cells may fight the infection when B cells and antibodies are depleted by drug treatment, researchers suggest. “We...

US regulators are stepping up scrutiny of cancer indications that were granted an accelerated approval on the basis of surrogate endpoints but that have failed to show clinical or survival benefits on...

In a major advance in the treatment of multiple myeloma, a CAR T-cell therapy has generated deep, sustained remissions in patients who had relapsed from several previous therapies, an international clinical...